IMNN
Imunon Inc
NASDAQ: IMNN · HEALTHCARE · BIOTECHNOLOGY
$2.83
+5.60% today
Updated 2026-04-30
Market cap
$10.98M
P/E ratio
—
P/S ratio
17.94x
EPS (TTM)
$-6.83
Dividend yield
—
52W range
$3 – $36
Volume
0.1M
Imunon Inc (IMNN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-123.8%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-361.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+8.1%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+13.5%
2025-12-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-31 | $-1.29 | — | $2.88 | $2.99 | +3.8% |
| 2025-12-31 | $-1.30 | +28.6% | $3.48 | $3.95 | +13.5% |
| 2025-11-13 | $-1.16 | -452.4% | $3.95 | $4.22 | +6.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | — | $-1.29 | — | — | — |
| 2025-12-31 | $-1.82 | $-1.30 | +28.6% | $-725202.00 | -199.7% |
| 2025-09-30 | $-0.21 | $-1.16 | -452.4% | — | — |
| 2025-06-30 | $-0.32 | $-1.87 | -484.4% | — | — |
| 2025-03-31 | $-0.57 | $-0.28 | +50.9% | — | — |
| 2024-12-31 | $-0.36 | $-0.25 | +30.6% | $727160.00 | -89.7% |
| 2024-09-30 | $-0.40 | $-0.34 | +15.0% | — | — |
| 2024-06-30 | $-0.54 | $-0.51 | +5.6% | — | — |
| 2024-03-31 | $-0.57 | $-0.52 | +8.8% | — | — |
| 2023-12-31 | $-0.41 | $-0.52 | -26.8% | $7.05M | — |
| 2023-09-30 | $-0.66 | $-0.37 | +43.9% | — | — |
Frequently asked questions
Has Imunon Inc beaten earnings estimates?
Imunon Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -123.8% over the last 3 quarters.
How does IMNN stock react to earnings?
IMNN stock has moved an average of +8.1% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.